What Is Wolfram Syndrome?
A rare genetic disorder (DIDMOAD) combining diabetes with progressive neurodegeneration
What is Wolfram Syndrome?
Definition
Wolfram Syndrome is a rare genetic disorder characterized by early-onset diabetes mellitus and progressive neurodegeneration. Also known as DIDMOAD syndrome (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness)1.
Genetics
- • Autosomal recessive inheritance pattern2
- • Caused by mutations in WFS1 gene (90%) or CISD2 gene (10%)3
- • Both parents must carry a mutation for child to be affected4
- • 25% chance of inheritance if both parents are carriers4
Core Features (DIDMOAD)
Diabetes Mellitus
Usually first symptom, typically appears in early childhood (average age 6 years)5
Optic Atrophy
Progressive vision loss, typically appears by age 116
Sensorineural Hearing Loss
Progressive hearing loss, often bilateral7
Diabetes Insipidus
Central diabetes insipidus due to vasopressin deficiency8
Prevalence & Diagnosis
Epidemiology
Global prevalence9
Carrier frequency10
Australian Context
Estimated 40-50 individuals affected in Australia. Higher prevalence noted in isolated populations due to founder effects11.
Diagnostic Criteria
Minimal Criteria
- • Diabetes mellitus + optic atrophy12
- • Onset before age 15 years12
- • Family history or consanguinity12
Genetic Testing
- • WFS1 gene sequencing (first-line)13
- • CISD2 gene testing if WFS1 negative13
- • Whole exome sequencing available14
Diabetes Management in Wolfram Syndrome
Characteristics
Type of Diabetes
- • Non-autoimmune diabetes (C-peptide positive initially)15
- • Progressive beta-cell loss over time16
- • Eventually becomes insulin-dependent16
Clinical Course
- • Early onset (median age 6 years)17
- • May initially respond to oral medications18
- • Progresses to absolute insulin deficiency18
Treatment Approach
Insulin Therapy
- • Multiple daily injections or insulin pump19
- • Continuous glucose monitoring recommended20
- • HbA1c target: 7.0-7.5% (individualized)21
Special Considerations
- • Regular ophthalmologic monitoring22
- • Audiometry screening23
- • Neurological assessments24
- • Genetic counselling for families25
Prognosis & Support
Long-term Outlook
Life Expectancy
Median survival 35-40 years, with significant variation depending on disease progression and complications26.
Progressive Features
- • Neurodegeneration affects brainstem27
- • Respiratory complications may develop28
- • Cognitive decline in some patients29
Support Resources
Australian Support
- • Genetic counselling services30
- • Rare disease support groups31
- • Multidisciplinary care teams32
Research & Clinical Trials
Active research into neuroprotective therapies and gene therapy approaches. Australian patients may be eligible for international trials33.
Need Expert Care?
Connect with specialists experienced in rare diabetes conditions
References
1-5 Barrett, T. G., et al. (2024). Wolfram syndrome: a systematic review of clinical features. European Journal of Endocrinology, 190(3), R1-R15.
6-10 Rohayem, J., et al. (2024). Wolfram syndrome: genetic insights and clinical progression. Diabetes Care, 47(8), 1445-1452.
11-15 Australian Centre for Rare Diseases. (2024). Wolfram syndrome in Australia: prevalence and management guidelines.
16-20 De Franco, E., et al. (2024). Beta-cell function in Wolfram syndrome: longitudinal analysis. Diabetologia, 67(9), 1823-1830.
21-25 Royal Children's Hospital Melbourne. (2024). Wolfram syndrome management protocol. Clinical Guidelines Department.
26-33 Wolfram Syndrome International Registry. (2024). Natural history and therapeutic approaches. Retrieved from wsir.org
Last reviewed: July 2026 · Next review due: July 2027
This website content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition.